John-Ross Rizzo | |
---|---|
![]() | |
Nationality | American |
Alma mater | New York University |
Employer | NYU Langone Medical Center |
Known for | Assistive technology, Eye–hand coordination |
Website | JohnRoss Rizzo-NYU School of Medicine, RizzoLab |
John-Ross (JR) Rizzo, M.D., M.S.C.I., is an American physician-scientist known for his contributions to the field of healthcare and rehabilitation. He holds the Melamid Professorship in Rehabilitation (Disability) Medicine at NYU Langone Medical Center. [1] Dr. Rizzo has made strides in the areas of disability inclusion, innovation, and equity within the medical community. At NYU Langone Medical Center, Dr. Rizzo serves as the first Health System Director of Disability Inclusion, which seeks to increase accessibility and inclusivity within healthcare. Additionally, he holds the position of Vice Chair of Innovation and Equity for the Department of Physical Medicine and Rehabilitation at the Rusk Institute of Rehabilitation Medicine. His affiliations include the Department of Neurology, where he contributes to the advancement of neurological sciences, as well as the Departments of Biomedical & Mechanical and Aerospace Engineering at New York University Tandon School of Engineering. Within Tandon, he also contributes to the Electrical and Computer Engineering Department as the associate director of Healthcare for the NYU Wireless Center. [2] Dr. Rizzo has published 125 peer-reviewed publications, contributed to 12 textbooks, and co-authored many conference proceedings. [3] [4] He has been funded by 5 federal agencies and lead/co-lead grants exceeding $10M. [5] [6] [7] [8] [9] [10]
Dr. Rizzo is the founding director of the Visuomotor Integration Laboratory (VMIL). [11] Within this innovative research space, his team explores the dynamics of eye-hand coordination and its relevance to neurological conditions. He also leads the REACTIV Laboratory (Rehabilitation Engineering Alliance and Center Transforming Low Vision) which seeks to address the challenges faced by individuals with visual impairments. [12] He and his team focus on developing low- and high-tech assistive technologies, with a special emphasis on wearables.
In addition to his academic and research pursuits, Dr. Rizzo was appointed in 2023 by Governor Kathy Hochul to the Board of Directors of The Metropolitan Transportation Authority (MTA). [13]
As a young boy, he was diagnosed with Choroideremia, a congenital, X-linked, recessive disease of the retina and choroid, associated with nyctalopia and degenerative peripheral vision. It has deeply influenced his thinking about functional dependencies and his professional goals.
Rizzo completed his undergraduate degree at New York University magna cum laude with an honors thesis in neural science and a double minor in chemistry and psychology. He was a Dean's Scholar and also conferred the Founders Day Award. He completed his medical school training on an academic scholarship at New York Medical College Alpha Omega Alpha (Iota Chapter) Honors and placed in top contention for his medical student research in neuro-ophthalmology under the tutelage of Prof. Sansar Sharma. His residency was completed at the Rusk Institute of Rehabilitation Medicine at New York University School of Medicine, where he completed a Chief Year and was selected for multiple leadership positions. His fellowship was completed in clinical research through the Physician Scientist Training Program at New York University School of Medicine’s Clinical and Translational Science Institute (CTSI) under a grant from the NIH (NCATS) in partnership with Rusk and the NYU Center for Neural Science / Dept. of Psychology under Prof.Michael S. Landy.
He has been a faculty member at NYU Langone Medical Center working on and creating teams that focus on a number of research foci since 2013. These include the Visuomotor Integration Laboratory (VMIL), focused on eye-hand coordination, as it relates to acquired brain injury (ABI), the REACTIV Laboratory (Rehabilitation Engineering Alliance and Center Transforming Low Vision), focuses on advanced wearables for the sensory deprived. [14]
His research explores how eye control intersects with hand control during eye-hand coordination after acquired brain injury (ABI) and what role vision and eye movements play in hand-focused motor recovery. Additionally, he focuses on leveraging technology to better objectify accepted clinical measures, to assist in instrumenting the medical ecosystem to improve medical science, and to create assistive technologies to help foster functional independence.
Rizzo has won awards for his work in disability research, particularly focused on the intersection of ocular motor and manual motor control and on assistive technology. He was awarded the Crain’s 40 under 40 award in New York Business for his medical devices, including his wearable technology. [15] In 2016, he was conferred the title of “Healthcare Re-writer” by Forbes and KPMG”. [16] Dr. Rizzo has also been featured in a number of lay articles and also featured in videos and press releases. In 2018, he was a highlighted speaker in NYU's TEDx “Re-Vision” Series. [17] in which he explains his life story and how he made turned his disability into a super power through the use of assistive technology and advanced wearables. [18] In 2018, ACRM recognized John-Ross Rizzo, for contributions to the field made during his early career work and he received the Deborah L. Wilkerson Early Career Award. [19] He was inducted into the Susan Daniels Disability Mentoring Hall of Fame that honors those who are making a significant difference in the lives of youth and adults with disabilities through mentoring and to raise awareness (Class of 2019). [20] He is also a recipient of the Rusk Leadership & Innovation Award. [21]
![]() | This article appears to contain a large number of buzzwords .(December 2021) |
Broadly, Rizzo focuses on the best innovation practices to support novel technologies in clinical applications. He has worked to quantitatively characterize accepted clinical measures and to instrument the medical ecosystem to create algorithmic approaches to care routines.
His research mission is broadly divided into two scientific domains.
The first domain is motor control and behavioral science in brain injury. He seeks to understand how eye control intersects with hand control during eye-hand coordination after acquired brain injury (ABI) and what role vision and eye movements play in motor recovery. His Team was instrumental in characterizing eye-hand dyscoordination in stroke and has worked to translate these findings to other patient populations. [22] The research was funded by the National Institutes of Health, among other foundations and governmental sponsors. [22] [23] [24]
His second domain is assistive technologies. He is designing mobility solutions for the visually impaired. Dr. Rizzo and his team have developed a new mechanical white cane that hybridizes the conventional cane with an adaptive mobility device called "DragonFly" which leverages a disparate navigation strategy that avoids the swinging and inefficiencies of current cane use, avoiding frequent musculoskeletal injuries and mitigating falls. [25] He and his team have also developed a new advanced wearable platform that can be considered a sensory augmentative aid with omnidirectional spatial perception. This device maps the environment in three dimensions through the use of distance and ranging sensors, along with sensor fusion, and then selectively re-displays the information via a torso-mounted haptic interface, vibrating the obstacles in the user's immediate vicinity onto their abdomen spatiotopically. Audio output is also leveraged through a bone conduction headset that also contains a microphone for voice control. The research was funded by the National Science Foundation, among other foundations, corporate sponsors, and governmental agencies. [26] [27] [28]
Hemiparesis, or unilateral paresis, is weakness of one entire side of the body. Hemiplegia is, in its most severe form, complete paralysis of half of the body. Hemiparesis and hemiplegia can be caused by different medical conditions, including congenital causes, trauma, tumors, or stroke.
Neurotrauma, brain damage or brain injury (BI) is the destruction or degeneration of brain cells. Brain injuries occur due to a wide range of internal and external factors. In general, brain damage refers to significant, undiscriminating trauma-induced damage.
Rehabilitation of sensory and cognitive function typically involves methods for retraining neural pathways or training new neural pathways to regain or improve neurocognitive functioning that have been diminished by disease or trauma. The main objective outcome for rehabilitation is to assist in regaining physical abilities and improving performance. Three common neuropsychological problems treatable with rehabilitation are attention deficit/hyperactivity disorder (ADHD), concussion, and spinal cord injury. Rehabilitation research and practices are a fertile area for clinical neuropsychologists, rehabilitation psychologists, and others.
Physical medicine and rehabilitation (PM&R), also known as physiatry, is a branch of medicine that aims to enhance and restore functional ability and quality of life to people with physical impairments or disabilities. This can include conditions such as spinal cord injuries, brain injuries, strokes, as well as pain or disability due to muscle, ligament or nerve damage. A physician having completed training in this field may be referred to as a physiatrist.
Bálint's syndrome is an uncommon and incompletely understood triad of severe neuropsychological impairments: inability to perceive the visual field as a whole (simultanagnosia), difficulty in fixating the eyes, and inability to move the hand to a specific object by using vision. It was named in 1909 for the Austro-Hungarian neurologist and psychiatrist Rezső Bálint who first identified it.
Visual or vision impairment is the partial or total inability of visual perception. For the former and latter case, the terms low vision and blindness respectively are often used. In the absence of treatment such as corrective eyewear, assistive devices, and medical treatment – visual impairment may cause the individual difficulties with normal daily tasks including reading and walking. In addition to the various permanent conditions, fleeting temporary vision impairment, amaurosis fugax, may occur, and may indicate serious medical problems.
Rusk Rehabilitation is the world's first and among the largest university-affiliated academic centers devoted entirely to inpatient/outpatient care, research, and training in rehabilitation medicine for both adults and pediatric patients. The system is part of the NYU Langone Medical Center and operated under the auspices of the Department of Rehabilitation Medicine of the New York University School of Medicine. The Rusk Institute is named in honor of its founder, Howard A. Rusk.
The Shirley Ryan AbilityLab, formerly the Rehabilitation Institute of Chicago (RIC), is a not-for-profit nationally ranked physical medicine and rehabilitation research hospital based in Chicago, Illinois. Founded in 1954, the AbilityLab is designed for patient care, education, and research in physical medicine and rehabilitation (PM&R). The AbilityLab specializes in rehabilitation for adults and children with the most severe, complex conditions ranging from traumatic brain and spinal cord injury to stroke, amputation and cancer-related impairment. Affiliated with Northwestern University, the hospital is located on Northwestern’s Chicago campus and partners on research and medical efforts.
Rehabilitation engineering is the systematic application of engineering sciences to design, develop, adapt, test, evaluate, apply, and distribute technological solutions to problems confronted by individuals with disabilities. These individuals may have experienced a spinal cord injury, brain trauma, or any other debilitating injury or disease. Functional areas addressed through rehabilitation engineering may include mobility, communications, hearing, vision, and cognition, and activities associated with employment, independent living, education, and integration into the community.
Virtual reality in telerehabilitation is a method used first in the training of musculoskeletal patients using asynchronous patient data uploading, and an internet video link. Subsequently, therapists using virtual reality-based telerehabilitation prescribe exercise routines via the web which are then accessed and executed by patients through a web browser. Therapists then monitor the patient's progress via the web and modify the therapy asynchronously without real-time interaction or training.
Neurorehabilitation is a complex medical process which aims to aid recovery from a nervous system injury, and to minimize and/or compensate for any functional alterations resulting from it.
MedStar National Rehabilitation Network is located in Washington, D.C., and specializes in treating persons with physical disabilities. The National Rehabilitation Hospital was founded in 1986 by Edward A. Eckenhoff, and is a member of the MedStar Health system, the Washington, D.C.-Baltimore region's largest non-profit healthcare organization.
NYU Langone Health is an academic medical center located in New York City, New York, United States. The organization consists of the NYU Grossman School of Medicine and NYU Grossman Long Island School of Medicine, both part of New York University (NYU), and more than 300 locations throughout the New York metropolitan area, including six inpatient facilities: Tisch Hospital; Kimmel Pavilion; NYU Langone Orthopedic Hospital; Hassenfeld Children's Hospital; NYU Langone Hospital – Brooklyn; and NYU Langone Hospital – Long Island. It is also home to Rusk Rehabilitation. NYU Langone Health is one of the largest healthcare systems in the Northeast, with more than 46,000 employees.
Traumatic brain injury can cause a variety of complications, health effects that are not TBI themselves but that result from it. The risk of complications increases with the severity of the trauma; however even mild traumatic brain injury can result in disabilities that interfere with social interactions, employment, and everyday living. TBI can cause a variety of problems including physical, cognitive, emotional, and behavioral complications.
Steven R. Flanagan is a nationally renowned expert in the field of traumatic brain injury (TBI) and is professor and chairman of the Department of Rehabilitation Medicine at the New York University School of Medicine, and the medical director of the Rusk Institute of Rehabilitation Medicine at the NYU Langone Medical Center.
Magee Rehabilitation Hospital, part of Jefferson Health, founded in 1958, is a 96-bed specialty medical rehabilitation hospital providing physical and cognitive rehabilitation services. Magee's flagship facility is located in Center City Philadelphia. In addition to the main campus that offers comprehensive services for spinal cord injury, brain injury, stroke, orthopaedic replacement, amputation, pain management and work injury, Magee provides an expanding outpatient network serving the surrounding communities. In 1985, Magee's brain injury rehabilitation program became the first in the nation to be accredited by the Commission on the Accreditation of Rehabilitation Facilities. Magee partnered with Jefferson Hospital to create one of the nation's 14 federally designated centers for spinal cord injury rehabilitation. Magee has been rated one of America's leading rehabilitation hospitals by U.S. News & World Report. Magee provides treatment to more than 5,000 individuals annually. Magee is authorized to treat wounded military personnel returning from war. Magee is not an Obligated Group Affiliate.
There are a variety of disabilities affecting cognitive ability. This is a broad concept encompassing various intellectual or cognitive deficits, including intellectual disability, deficits too mild to properly qualify as intellectual disability, various specific conditions, and problems acquired later in life through acquired brain injuries or neurodegenerative diseases like dementia.
Spastic cerebral palsy is the type of cerebral palsy characterized by spasticity or high muscle tone often resulting in stiff, jerky movements. Cases of spastic CP are further classified according to the part or parts of the body that are most affected. Such classifications include spastic diplegia, spastic hemiplegia, spastic quadriplegia, and in cases of single limb involvement, spastic monoplegia.
The Center for Neurotechnology (CNT) is an Engineering Research Center funded by the National Science Foundation to create devices to restore the body's capabilities for sensation and movement. The National Science Foundation has awarded the CNT $~30 million since 2011.
Bernhard Sabel is a German neuropsychologist and brain researcher. His more than 40 years of research are documented in over 200 publications, investigating treatment options for visual impairments through the activation and rehabilitation of residual vision capabilities.
{{cite journal}}
: Cite journal requires |journal=
(help){{cite journal}}
: Cite journal requires |journal=
(help){{cite journal}}
: Cite journal requires |journal=
(help)